Nifty
Sensex
:
:
23349.90
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)

Chemicals

Rating :
N/A

BSE: 543389 | NSE: SIGACHI

61.51
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  62.80
  •  63.00
  •  61.25
  •  62.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1112135
  •  687.66
  •  95.90
  •  43.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,590.88
  • 24.07
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,677.71
  • 0.21%
  • 3.37

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.71%
  • 3.12%
  • 45.10%
  • FII
  • DII
  • Others
  • 1.58%
  • 0.00%
  • 5.49%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 23.47
  • 16.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 25.36
  • 7.64

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 22.99
  • 12.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 28.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 4.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 20.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
124.90
99.18
25.93%
95.71
84.70
13.00%
104.13
72.42
43.79%
110.95
68.85
61.15%
Expenses
107.68
77.76
38.48%
74.69
68.39
9.21%
87.80
60.24
45.75%
88.36
54.83
61.15%
EBITDA
17.23
21.42
-19.56%
21.03
16.31
28.94%
16.33
12.18
34.07%
22.59
14.01
61.24%
EBIDTM
13.79%
21.60%
21.97%
19.26%
15.68%
16.81%
20.36%
20.35%
Other Income
14.64
1.11
1,218.92%
1.68
1.63
3.07%
7.24
1.55
367.10%
1.71
1.29
32.56%
Interest
2.10
1.79
17.32%
3.16
1.27
148.82%
2.87
1.41
103.55%
1.84
1.20
53.33%
Depreciation
3.22
2.52
27.78%
3.15
1.96
60.71%
3.49
1.98
76.26%
2.82
1.78
58.43%
PBT
26.55
18.21
45.80%
16.39
14.71
11.42%
17.21
10.33
66.60%
19.64
12.32
59.42%
Tax
5.53
3.10
78.39%
3.63
3.83
-5.22%
2.04
3.02
-32.45%
3.54
2.50
41.60%
PAT
21.02
15.12
39.02%
12.76
10.88
17.28%
15.17
7.32
107.24%
16.11
9.82
64.05%
PATM
16.83%
15.24%
13.33%
12.84%
14.57%
10.10%
14.52%
14.27%
EPS
0.65
0.49
32.65%
0.40
0.34
17.65%
0.46
0.24
91.67%
0.50
0.32
56.25%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
435.69
398.96
302.05
250.29
192.76
139.06
128.99
100.73
Net Sales Growth
34.00%
32.08%
20.68%
29.85%
38.62%
7.81%
28.06%
 
Cost Of Goods Sold
215.67
195.14
138.38
118.60
100.73
72.09
66.69
58.79
Gross Profit
220.02
203.82
163.67
131.70
92.03
66.97
62.30
41.94
GP Margin
50.50%
51.09%
54.19%
52.62%
47.74%
48.16%
48.30%
41.64%
Total Expenditure
358.53
322.31
243.32
197.25
153.97
114.30
103.03
89.00
Power & Fuel Cost
-
10.27
6.62
5.44
4.40
4.11
4.08
3.71
% Of Sales
-
2.57%
2.19%
2.17%
2.28%
2.96%
3.16%
3.68%
Employee Cost
-
50.33
32.23
16.55
13.93
11.71
10.18
7.73
% Of Sales
-
12.62%
10.67%
6.61%
7.23%
8.42%
7.89%
7.67%
Manufacturing Exp.
-
20.95
18.47
14.90
14.15
11.02
10.06
8.76
% Of Sales
-
5.25%
6.11%
5.95%
7.34%
7.92%
7.80%
8.70%
General & Admin Exp.
-
23.70
20.03
11.65
10.37
8.52
6.00
3.74
% Of Sales
-
5.94%
6.63%
4.65%
5.38%
6.13%
4.65%
3.71%
Selling & Distn. Exp.
-
20.82
26.30
29.22
9.94
6.59
5.67
5.98
% Of Sales
-
5.22%
8.71%
11.67%
5.16%
4.74%
4.40%
5.94%
Miscellaneous Exp.
-
1.09
1.29
0.90
0.44
0.27
0.34
0.29
% Of Sales
-
0.27%
0.43%
0.36%
0.23%
0.19%
0.26%
0.29%
EBITDA
77.18
76.65
58.73
53.04
38.79
24.76
25.96
11.73
EBITDA Margin
17.71%
19.21%
19.44%
21.19%
20.12%
17.81%
20.13%
11.64%
Other Income
25.27
11.69
6.67
2.63
3.25
4.89
3.89
3.05
Interest
9.97
7.77
4.29
1.17
1.25
2.34
3.45
3.79
Depreciation
12.68
10.80
6.63
2.90
2.31
1.96
1.67
1.39
PBT
79.79
69.77
54.48
51.60
38.48
25.34
24.73
9.60
Tax
14.74
12.51
10.94
11.56
8.22
5.03
5.72
2.68
Tax Rate
18.47%
17.93%
20.08%
22.40%
21.36%
19.85%
23.13%
27.92%
PAT
65.06
57.18
43.54
40.04
30.26
20.32
19.01
6.92
PAT before Minority Interest
66.11
57.27
43.54
40.04
30.26
20.32
19.01
6.92
Minority Interest
1.05
-0.09
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
14.93%
14.33%
14.41%
16.00%
15.70%
14.61%
14.74%
6.87%
PAT Growth
50.81%
31.33%
8.74%
32.32%
48.92%
6.89%
174.71%
 
EPS
1.95
1.72
1.31
1.20
0.91
0.61
0.57
0.21

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
429.64
268.36
227.78
94.20
64.59
44.88
26.34
Share Capital
32.82
30.74
30.74
7.68
7.68
3.07
3.07
Total Reserves
338.76
237.62
197.04
86.52
56.90
41.81
23.27
Non-Current Liabilities
65.30
30.76
7.58
7.03
5.47
4.46
5.98
Secured Loans
26.58
1.01
1.21
1.89
1.91
1.23
3.33
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.83
1.49
0.92
0.78
0.71
0.54
0.58
Current Liabilities
187.82
74.63
51.44
32.18
39.09
42.12
39.97
Trade Payables
47.90
20.85
10.60
7.95
7.23
8.84
8.36
Other Current Liabilities
45.09
14.29
6.44
5.07
4.70
6.90
4.85
Short Term Borrowings
92.44
39.48
33.12
18.31
27.03
22.03
25.01
Short Term Provisions
2.39
0.00
1.28
0.85
0.13
4.34
1.74
Total Liabilities
694.15
373.75
286.80
133.41
109.15
91.46
72.29
Net Block
254.24
122.31
53.41
37.96
31.59
28.52
25.89
Gross Block
305.33
144.61
69.09
50.73
42.05
37.02
32.85
Accumulated Depreciation
51.09
22.30
15.68
12.77
10.46
8.51
6.96
Non Current Assets
380.89
196.33
106.93
46.28
37.07
32.18
27.85
Capital Work in Progress
97.27
34.90
9.71
3.74
3.13
2.29
0.69
Non Current Investment
0.29
0.15
0.15
0.15
0.00
0.00
0.06
Long Term Loans & Adv.
14.65
20.97
11.75
4.43
2.35
1.38
1.21
Other Non Current Assets
14.45
18.00
31.91
0.00
0.00
0.00
0.00
Current Assets
313.26
177.41
179.87
87.13
72.07
59.28
44.44
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
70.72
46.60
30.45
21.20
27.92
22.56
15.97
Sundry Debtors
150.04
80.17
60.12
35.76
27.60
24.70
21.19
Cash & Bank
57.06
32.76
69.38
18.02
10.59
2.13
2.57
Other Current Assets
35.45
3.38
5.29
6.44
5.95
9.89
4.70
Short Term Loans & Adv.
22.61
14.50
14.62
5.71
2.62
4.46
2.19
Net Current Assets
125.44
102.79
128.42
54.95
32.98
17.16
4.47
Total Assets
694.15
373.74
286.80
133.41
109.14
91.46
72.29

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
12.89
29.02
5.85
29.55
12.14
14.46
6.24
PBT
69.77
54.48
51.60
38.48
25.34
24.73
9.60
Adjustment
9.63
7.76
2.76
3.53
4.02
4.90
5.17
Changes in Working Capital
-57.13
-20.48
-36.92
-5.82
-12.36
-10.14
-5.81
Cash after chg. in Working capital
22.27
41.76
17.44
36.19
17.00
19.49
8.96
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.38
-12.74
-11.59
-6.73
-4.86
-5.10
-2.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.09
0.00
0.07
0.00
Cash From Investing Activity
-160.74
-91.85
-62.86
-11.43
-6.82
-5.96
-3.79
Net Fixed Assets
-81.73
-100.12
-24.33
-9.29
-5.87
-5.77
Net Investments
-100.00
-1.57
0.00
-0.15
0.00
0.06
Others
20.99
9.84
-38.53
-1.99
-0.95
-0.25
Cash from Financing Activity
172.10
26.21
108.37
-10.69
3.14
-8.93
-3.16
Net Cash Inflow / Outflow
24.25
-36.63
51.37
7.43
8.46
-0.43
-0.71
Opening Cash & Equivalents
32.81
69.38
18.02
10.59
2.13
2.57
3.27
Closing Cash & Equivalent
57.06
32.76
69.38
18.02
10.59
2.13
2.57

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
11.32
8.73
7.41
40.87
84.07
146.06
85.72
ROA
10.73%
13.18%
19.06%
24.95%
20.25%
23.22%
9.58%
ROE
17.90%
17.55%
24.87%
38.11%
37.12%
53.39%
26.28%
ROCE
17.90%
20.53%
27.93%
37.83%
33.55%
44.44%
23.60%
Fixed Asset Turnover
1.77
2.83
4.18
4.15
3.52
3.69
3.07
Receivable days
105.31
84.77
69.91
59.99
68.65
64.94
76.80
Inventory Days
53.67
46.55
37.66
46.51
66.26
54.52
57.88
Payable days
64.29
41.48
28.55
27.51
26.11
30.87
33.95
Cash Conversion Cycle
94.68
89.84
79.02
78.99
108.79
88.59
100.73
Total Debt/Equity
0.34
0.15
0.15
0.22
0.47
0.56
1.15
Interest Cover
9.98
13.69
45.08
31.79
11.81
8.17
3.53

News Update:


  • Sigachi Industries unveils new product lines ‘PureCoat’, ‘UltraMod’
    20th Aug 2024, 11:43 AM

    These cutting-edge solutions are poised to transform the coatings landscape, enhancing drug delivery, patient compliance, and overall product efficacy

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.